Leaning into the Trump trade side of election outcomes, says Stifel's Brian Gardner
Cornell Belcher, Brilliant Corners Research's founder and president, and Brian Gardner, Stifel's chief Washington policy ...
Crispr Therapeutics price target lowered to $53 from $59 at Stifel
Stifel lowered the firm’s price target on Crispr Therapeutics (CRSP) to $53 from $59 and keeps a Hold rating on the shares following the ...
Yahoo Finance1d
OnKure to Present at the Stifel 2024 Healthcare Conference
will present a corporate overview at the Stifel Healthcare Conference, on November 18, 2024 at 1:50 p.m. ET in New York, NY ...
InvestmentNews5d
B. Riley keeps indy reps after selling employees to Stifel for far less than expected
Eric Lyon, a former senior managing director, B. Riley Wealth Management, jumped to Kestra Investment Services at the start ...
IDEAYA Biosciences (IDYA) Gets a Buy from Stifel Nicolaus
In a report released yesterday, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on IDEAYA Biosciences (IDYA – Research ...
B. Riley to sell part of wealth management business to Stifel
Investment bank B. Riley Financial said on Friday it had agreed to sell a portion its traditional wealth management business ...
B. Riley Sells Part of Wealth Unit to Stifel Amid Broker Exits
B. Riley Financial Inc. agreed to sell a portion of its wealth-management business to Stifel Financial Corp. for as much as ...
The Business Journals2d
St. Louis financial services giant to pay up to $35M for part of wealth management business
Riley Financial Inc. (NASDAQ: RILY), a Los Angeles-based brokerage and investment bank, said it has agreed to sell part of its "traditional" wealth management business to St. Louis-based Stifel ...
ETF Daily News3d
Stifel Financial Corp. (NYSE:SF) Receives $100.33 Consensus Target Price from Brokerages
Stifel Financial Corp. (NYSE:SF – Get Free Report) has received a consensus rating of “Hold” from the seven ratings firms that are covering the company, MarketBeat Ratings reports.
Personalis to Present at the Stifel 2024 Healthcare Conference
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the Stifel 2024 Healthcare Conference on Tuesday, ...
Business Insider1d
Portillo’s downgraded to Hold from Buy at Stifel
Stifel analyst Chris O’Cull downgraded Portillo’s (PTLO) to Hold from Buy with a $13 price target The company reported disappointing same-restaurant-sales and traffic performance, with EBITDA above ...